Todd M Hansen

This inventor holds 32 USPTO granted patents and 32 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignees: Abbvie Inc., Abbott Laboratories Corporation, Genentech, Inc.. Active years: 2006-2024.

USPTO Granted Patents = 32 (Patent Applications = 32)

% Patents Active = 84.4

CIPO Patents = 3 (Patent Applications = 14)

EPO Patents = 6 (Patent Applications = 18)

Average Co-Inventor Count = 11.4

ph-index = 10

Forward Citations = 314(Granted Patents)

Location History:

Gurnee, IL (US) (2012)
Grayslake, IL (US) (2006 - 2024)

Company Filing History:

Abbott Laboratories Corporation

Walter and Eliza Hall Institute of Medical Research

patents

where one patent can have more than one assignee

Years Active: 2006-2024

Loading Chart...

Areas of Expertise:

Apoptosis Inducing Agents

Cancer Treatment

Immune Diseases

Autoimmune Diseases

NAMPT Inhibitors

BCL-2 Selective Agents

CDK9 Kinase Inhibitors

Diacylglycerol O-Acyltransferase Inhibitors

Acetyl-CoA Carboxylase Inhibitors

Thienopyridones

AMPK Activators

Antibacterial Compounds

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11897864 - Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases (2024-02-13),

2. 11786519 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2023-10-17),

3. 10093624 - NAMPT and ROCK inhibitors (2018-10-09),

4. 9994581 - Bromodomain inhibitors (2018-06-12),

5. 9877958 - Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases (2018-01-30),

6. 9844547 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2017-12-19),

7. 9796708 - Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors (2017-10-24),

8. 9758511 - NAMPT inhibitors (2017-09-12),

9. 9334264 - NAMPT inhibitors (2016-05-10),

10. 9302989 - NAMPT and rock inhibitors (2016-04-05),

11. 9296723 - NAMPT inhibitors (2016-03-29),

12. 9266877 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2016-02-23),

13. 9227963 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2016-01-05),

14. 9193723 - NAMPT inhibitors (2015-11-24),

15. 9187472 - NAMPT inhibitors (2015-11-17),

Title: Todd M Hansen: Pioneering Inventor from Grayslake, IL

Introduction: Todd M Hansen is a distinguished inventor hailing from Grayslake, Illinois, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Todd M Hansen's latest patents include cutting-edge advancements in artificial intelligence, renewable energy solutions, and sustainable materials.

Career Highlights: With over two decades of experience in the industry, Todd M Hansen has a proven track record of developing innovative solutions that have revolutionized various sectors, from healthcare to telecommunications.

Collaborations: Throughout his career, Todd M Hansen has collaborated with leading research institutions, universities, and tech companies to bring his visionary ideas to life, resulting in impactful inventions that have shaped the modern technological landscape.

Conclusion: Todd M Hansen's relentless passion for innovation and his commitment to pushing the boundaries of what is possible make him a true trailblazer in the world of inventions.